Fingerprint
Dive into the research topics of 'Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): A trial of the Eastern Cooperative Oncology Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically